Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?

P. Masand,Sanjay Gupta,T. Schwartz,D. Kaplan,S. Virk,A. Hameed,K. Lockwood
DOI: https://doi.org/10.1176/APPI.PSY.43.6.451
2002-11-01
Psychosomatics
Abstract:Irritable bowel syndrome (IBS) is the most common disorder in patients seen by gastroenterologists. Twenty subjects with IBS diagnosed with the Rome criteria were treated for 12 weeks with 20-40 mg/day of paroxetine (mean dose=31 mg/day). At baseline, 10 patients had a lifetime history of an anxiety disorder, and 10 patients did not have such a history. Both groups had similar improvement in abdominal pain, constipation, diarrhea, incomplete emptying, and bloating/ abdominal distension. Paroxetine was very well tolerated.
What problem does this paper attempt to address?